Urology

publication venue for

Ischemic Priapism in a 12 Year Old Patient Associated With Coronavirus Disease 2019 (COVID-19): A Case Report. 2022
The Impact of Physician Productivity Models on Access to Subspecialty Care: A White Paper From the Society for the Study of Male Reproduction and the Society for Male Reproduction and Urology. 2021
Upper Tract Urothelial Carcinoma in a Patient With Horseshoe Kidney. 2020
Co-Manifestations of Genital Neurofibromatosis in a Patient with Neurofibromatosis Type 1. 2020
Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience. 2018
Robotic Left-sided Level II Caval Thrombectomy and Nephrectomy Using a Novel Supine, Single-dock Approach: Primary Description. 2017
Intraductal Carcinoma of the Prostate: A Risk for Rapid Recurrence. 2017
The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. 2016
Clinical, radiographic, and pathologic description of IgG4-related perivasal fibrosis: a previously undescribed etiology of chronic orchialgia. 2014
A case of penetrating glass foreign body within the renal cortex. 2014
Prolapse of a single system large ureterocele containing multiple stones in a pregnant woman. 2014
A 60-year-old woman with an incidentally discovered right renal mass. 2012
Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer. 2012
Primary carcinoid tumor of urinary bladder discovered on pelvic magnetic resonance imaging. 2012
A 38-year-old woman with multiple renal masses and a history of ovarian cancer. 2012
Müllerian remnant malignancy. 2012
Robot-assisted tapered ureteral reimplantation for congenital megaureter. 2011
Incidental ureteral catheterization with cystometry catheter during video urodynamics: a prompt diagnosis. 2011
Successful percutaneous transperineal drainage of a large prostatic abscess. 2010
Residual prostate tissue after radical prostatectomy: acceptable surgical complication or treatment failure? 2010
Retroperitoneal Castleman's disease. 2010
A report of an iatrogenic bladder rupture in a normal healthy child during voiding cystourethrography. 2009
Pelvic cake kidney with a solitary ureter and bilateral congenital absence of the vas deferens. 2009
Sign of the fox. 2008
Scrotal ulcer after intraperitoneal hyperthermic chemotherapy. 2007
Antidepressant-associated changes in semen parameters. 2007
Long-term response with sunitinib for metastatic renal cell carcinoma. 2006
Synchronous unilateral renal cell carcinoma and Kimura disease of the kidney. 2006
Arteriovenous malformation of scrotum causing virtual azoospermia. 2006
Violaceous exanthem as a manifestation of metastatic prostate cancer in skin. 2006
Metastatic renal cell carcinoma to the nose and ethmoid sinus. 2006
Gastrointestinal hemorrhage as first manifestation of metastatic testicular tumor. 2005
Hypoechoic testicular mass: a case of testicular and epididymal sarcoidosis. 2005
Neuromuscular complications after percutaneous radiofrequency ablation of renal tumors. 2005
Page kidney as a complication of percutaneous antegrade endopyelotomy. 2005
Small (less than 1.5 cm) renal tumor with confirmed lung metastases. 2005
Mucinous adenocarcinoma of the prostate: a case report of long-term disease-free survival and a review of the literature. 2004
Renal angiomyolipoma with contrast-enhancing elements mimicking renal malignancy: radiographic and pathologic evaluation. 2004
Distinguishing splenosis from renal masses using ferumoxide-enhanced magnetic resonance imaging. 2003
Presacral cystic schwannoma in a man. 2003
Rare case of metastatic prostate adenocarcinoma to the pituitary. 2003
Henoch-Schonlein purpura involving the glans penis. 2003
National Comprehensive Cancer Network guidelines for the management of prostate cancer. 2003
Prostate adenocarcinoma presenting with inguinal lymphadenopathy. 2003
Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma. 2002
A rare case of painless gross hematuria: primary localized AA-type amyloidosis of the urinary bladder. 2002
Massive hematuria due to right renal artery mycotic pseudoaneurysm in a patient with subacute bacterial endocarditis. 2001
Magnetic resonance imaging in the evaluation of congenital anomalies of the external genitalia. 2001
The "bends" and neurogenic bladder dysfunction. 2001
Renal mass within a horseshoe kidney: preoperative evaluation with three-dimensional helical computed tomography. 2001
Acquired hypogonadotropic hypogonadism presenting as decreased seminal volume. 2000
Undifferentiated sex cord/stromal testis tumor. 2000
Renal cell carcinoma with an infrarenal vena caval tumor thrombus. 1999
Localized squamous cell carcinoma of the bladder causing hypercalcemia and inhibition of PTH secretion. 1998
Polymerase chain reaction used to detect candidemia in patients with candiduria. 1998
Laparoscopic resection of intra-abdominal testicular tumor. 1998
Laparoscopic surgery in children with ventriculoperitoneal shunts: effect of pneumoperitoneum on intracranial pressure--preliminary experience. 1997
Testicular microlithiasis as a predictor of intratubular germ cell neoplasia. 1996
Benign ectopic prostatic tissue involving the seminal vesicle in a patient with prostate cancer: recognition and implications for staging. 1996
Balloon-wire retrieval of a migrated urethral stent in the early postoperative period. 1996
Bladder calcifications after photodynamic therapy: analysis of a rare complication. 1996
Magnetic resonance imaging of vascular lesions of the scrotum and penis. 1995
Staphylococcus periprostatic abscess: an unusual cause of acute urinary retention. 1995
Postradical orchiectomy hemorrhage: should an alteration in staging strategy for testicular cancer be considered? 1995
Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma. 1995
Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder. 1995
An unusual cause of duodenal obstruction: ureteropelvic junction obstruction and the renoalimentary relationship. 1994
Management and evaluation of localized amyloidosis of the bladder: two case reports. 1994
Secondary carcinoma of kidney from parotid gland tumor. 1993
Untreated hypernephroma of thirty-three years. 1993
Sarcomatoid renal carcinoma with angiosarcomatoid component. Light microscopic and immunohistochemical study. 1992
Sonographic monitoring of prostate cancer after definitive radiotherapy. 1992
Chronic renal failure secondary to post-hysterectomy vaginal prolapse. 1991
Perirenal lipoma versus renal cell carcinoma. 1991
Renal cell metastases versus liver hemangioma. 1991
Management of urinary retention due to benign prostatic hyperplasia using luteinizing hormone-releasing hormone agonist. 1989
Metaplastic cystitis complicated with Von Brunn nests, cystitis cystica, and intestinal type of glandular metaplasia. 1988
Kaposi sarcoma of penis and genitalia: a disease of our times. 1988
Voiding dysfunction in tertiary syphilis. 1987
Hemorrhage: a complication of metastatic testicular choriocarcinoma. 1987
Brain metastases from carcinoma of bladder. 1987
Total replacement of bladder and urethra by cecum and appendix in bladder exstrophy. 1986
Preoperative assessment of retroperitoneal pathology by magnetic resonance imaging. Primary leiomyosarcoma of inferior vena cava. 1986
Persistent müllerian structures in infertile male. 1986
Magnetic resonance imaging: its application to male infertility. 1986
Treatment of malakoplakia of bladder with intravesical neosporin irrigation. 1986
Case profile: Crossed fused ectopia misdiagnosed as retroperitoneal tumor. 1985
Male infertility due to communicating bilateral varicoceles. 1984
Ureteral stent in management of fungal pyonephrosis due to Torulopsis glabrata. 1984
Penile replantation. 1983
Father-son testicular (teratocarcinoma) malignancy. 1983
Congenital hemihypertrophy with adrenal carcinoma and medullary sponge kidney. 1983
Orbital metastases from prostatic carcinoma. 1982
Henoch-Schönlein purpura associated with cancer of prostate. 1982
Renal vein thrombosis in renal cell carcinoma. Proteinuria as diagnostic sign. 1982
Retroperitoneal lymphadenectomy for germ cell tumor of testis in association with horseshoe kidney. 1981
Psuedocrossed renal ectopia secondary to retroperitoneal liposarcoma. 1981
Automated flow cytometry to monitor intravesical BCG therapy of superficial bladder cancer. 1981
Basal cell carcinoma of scrotum. 1981
Ganglioneuroma arising in accessory adrenal gland. 1980
Hemosiderosis of urinary bladder. 1979
Agranulocytosis associated with flucytosine for urinary candidiasis. 1976
Renal cell carcinoma metastatic to urinary bladder. 1976
Infarction of testicle and Schistosoma mansoni. 1975
Pseudocyst of pancreas simulating a renal neoplasm. 1975
Longitudinal Changes in the Operative Experience for Junior Urology Residents. 2023
Adoption and Outcomes of HoLEP in the United States. 2023
Comparison of Postoperative Outcomes of Trans-urethral Resection of the Prostate, Laser Vaporization, and Laser Enucleation: A Double Propensity Score Matched Analysis. 2023
Change in Prostate Volume and Symptom Improvement in Men Treated With Rezūm Water Vapor Therapy. 2023
Current Practice Patterns in the Surgical Management of Benign Prostatic Hyperplasia.. 175. 2023
Unilateral Scrotal Swelling: Diagnosis and Management.. 175. 2023
Prosteria - National Trends and Outcomes of More Frequent Than Guideline Recommended Prostate Specific Antigen Screening.. 174. 2023
Trends in Antimicrobial Prophylaxis for Inflatable Penile Prosthesis Surgery From a Large National Cohort.. 172. 2022
Effect of Surgeon and Facility Volume on Outcomes of Benign Prostatic Hyperplasia Surgery: Implications of Disparities in Access to Care at High-Volume Centers.. 172. 2022
Perioperative Nephrectomy Outcomes for Patients with Liver Disease: Implications for Liver Transplant Candidates.. 173. 2022
Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation.. 170. 2022
Predictors and Trends of Opioid-Sparing Radical Prostatectomy From a Large National Cohort.. 168. 2022
Aquablation Outcomes in Men With LUTS Due to BPH Following Single Versus Multi-pass Treatments.. 169. 2022
Microsurgical Excision of a Supernumerary Testis: A Novel Technique to Avoid Iatrogenic Injury to the Adjacent Testis.. 169. 2022
The Lack of a Physical Exam During New Patient Telehealth Visits Does Not Impact Plans for Office and Operating Room Procedures.. 167. 2022
Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series.. 167. 2022
WATER vs WATER II 3-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80 cc and 80-150 cc Prostates.. 165. 2022
Large, Multi-Center, Prospective Registry of Rezūm Water Vapor Therapy for Benign Prostatic Hyperplasia.. 165. 2022
Pilot Study of "Less is More" Rezum for Treatment of BPH.. 165. 2022
Medical Malpractice Lawsuits Involving Urology Trainees.. 166. 2022
Longitudinal Changes in the Pelvic Pain Only and Widespread Pain Phenotypes Over One Year in the MAPP-I Urologic Chronic Pelvic Pain Syndrome (UCPPS) Cohort.. 161. 2022
Authorship Gender Composition in Urology Literature From 2015 Through 2020.. 165. 2022
Consumption of a Healthy Plant-based Diet is Associated With a Decreased Risk of Erectile Dysfunction: A Cross-sectional Study of the National Health and Nutrition Examination Survey.. 161. 2022
The Future is Female: The Influence of Female Faculty and Resident Representation on Female Applicant Match Rate Amongst Urology Residency Programs Over 3 Years.. 160. 2021
Characterization of a Novel Implant Intended to Expand and Reshape the Prostatic Urethra for the Treatment of Benign Prostatic Hyperplasia: A Pre-Clinical Feasibility Study in the Canine Model.. 159. 2021
Development and Usability Testing of a Mobile Application to Monitor Patient-Reported Outcomes after Stress Urinary Incontinence Surgery.. 159. 2021
Noncancerous Genitourinary Conditions as a Public Health Priority: Conceptualizing the Hidden Burden.. 166. 2021
Prostate Cancer Screening for Gay Men in the United States.. 163. 2021
Impact of Plant-Based Diet on PSA Level: Data From the National Health and Nutrition Examination Survey.. 156. 2021
Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation.. 155. 2021
The Mechanism of Action of cTIND for Minimally Invasive Ischemic Incision of the Prostate: In Vivo Study.. 157. 2021
The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma.. 154. 2021
Influence of Department Leadership on Scholarly Productivity and Research Funding in Academic Urology.. 154. 2021
The iTind Temporarily Implanted Nitinol Device for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Multicenter, Randomized, Controlled Trial.. 153. 2020
Epidemiology and Diagnosis of Erectile Dysfunction by Urologists Versus Non-Urologists in the United States: An Analysis of the National Ambulatory Medical Care Survey.. 147. 2020
Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis.. 146. 2020
Variations in Perioperative Antibiotic Prescriptions Among Academic Urologists After Ambulatory Endoscopic Urologic Surgery: Impact on Infection Rates and Validation of 2019 Best Practice Statement.. 146. 2020
RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.. 144. 2020
Ejaculatory Hood-Sparing Vaporization of the Prostate and Its Impact on Erectile, Ejaculatory, and Sexual Function.. 144. 2020
Transvaginal Paravaginal Native Tissue Anterior Repair Technique: Initial Outcomes.. 150. 2020
Patient-Reported Quality of Life and Convalescence After Minimally Invasive Kidney Cancer Surgery.. 144. 2020
The Association Between 24-Hour Urine and Stone Recurrence Among High Risk Kidney Stone Formers: A Population Level Assessment.. 144. 2020
Gender Bias in Medicine: Does It Exist at AUA Plenary Sessions?. 150. 2020
Historical Perspective on Partial Nephrectomy and Renal Functional Preservation.. 145. 2020
Use of a Risk Stratification Tool to Guide Evaluation of Patients With Asymptomatic Microscopic Hematuria.. 141. 2020
Metabolic Syndrome Predicts Worse Perioperative Outcomes in Patients Treated With Partial Nephrectomy for Renal Cell Carcinoma.. 140. 2020
Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members.. 139. 2020
Prostate Multiparametric Magnetic Resonance Imaging Features Following Partial Gland Cryoablation.. 138. 2020
Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States.. 137. 2020
Increased Risk of Hypogonadal Symptoms in Shift Workers With Shift Work Sleep Disorder.. 138. 2020
Risk Factors for Infection after Prostate Biopsy in the United States.. 138. 2019
Comparison of Urologic Transfers to Academic Medical Centers: A Multi-institutional Perspective.. 136. 2019
A Systematic Review and Evidence-based Analysis of Ingredients in Popular Male Fertility Supplements.. 136. 2019
A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy.. 135. 2019
Persistent Discordance in Grade, Stage, and NCCN Risk Stratification in Men Undergoing Targeted Biopsy and Radical Prostatectomy.. 135. 2019
Ejaculatory Preserving Middle Lobe Onl-Transurethral Resection and Vaporization of the Prostate: 12-Year Experience.. 134. 2019
Robot-assisted Laparoscopic Extravesical Cross-trigonal Ureteral Reimplantation With Tailoring for Primary Obstructive Megaureter.. 134. 2019
Upper Pole Access for Prone Percutaneous Nephrolithotomy: Advantage or Risk?. 134. 2019
The Management and Efficacy of Surgical Techniques Used for Erosive Mesh in the Urethra and Bladder: A Systematic Review.. 134. 2019
Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer.. 131. 2019
Distribution of Semen Parameters Among Adolescent Males Undergoing Fertility Preservation in a Multicenter International Cohort.. 127. 2019
Symptom Duration in Patients With Urologic Chronic Pelvic Pain Syndrome is not Associated With Pain Severity, Nonurologic Syndromes and Mental Health Symptoms: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Network Study.. 124. 2018
Patient Decision-making and Predictors of Genital Satisfaction Associated With Testicular Prostheses After Radical Orchiectomy: A Questionnaire-based Study of Men With Germ Cell Tumors of the Testicle.. 124. 2018
An Infertile Couple's Long and Expensive Path to Varicocele Repair.. 124. 2018
Reduced Recurrence of Low-grade Papillary Bladder Tumors Associated With Asymptomatic Bacteriuria.. 124. 2018
Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.. 124. 2018
Comparison of Postradical Cystectomy Ileus Rates Using GIA-80 Versus GIA-60 Intestinal Stapler Device.. 122. 2018
Validation of a Simulation-training Model for Robotic Intracorporeal Bowel Anastomosis Using a Step-by-step Technique.. 120. 2018
The Impact of Microsurgical Repair of Subclinical and Clinical Varicoceles on Total Motile Sperm Count: Is There a Difference?. 120. 2018
Patient-specific Virtual Simulation-A State of the Art Approach to Teach Renal Tumor Localization.. 120. 2018
Histologic and Oncologic Outcomes Following Liver Mass Resection With Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Germ Cell Tumor.. 118. 2018
Clinical Outcome of Retroperitoneal Lymph Node Dissection after Chemotherapy in Patients with Pure Embryonal Carcinoma in the Orchiectomy Specimen.. 114. 2018
The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study.. 111. 2017
Organ Preservation Is Less Frequently Performed in Women Surgically Treated for Papillary Renal Cell Carcinoma-Results of a Comprehensive Multicenter Study.. 109. 2017
Scrotal Ultrasound for Pain: Low Frequency of Absolute Surgical Indications.. 108. 2017
Twitter Activity Associated With U.S. News and World Report Reputation Scores for Urology Departments.. 108. 2017
Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.. 106. 2017
Malignant Mesothelioma of the Tunica Vaginalis Testis: Outcomes Following Surgical Management Beyond Radical Orchiectomy.. 107. 2017
From Galen's Urine to Harvey's Blood.. 106. 2017
The First Filmed Prostatectomy, 1917: 100 Years of Movies in Urological Education.. 105. 2017
Robot-assisted Laparoscopic Resection of Renal Vein Leiomyosarcoma.. 103. 2017
Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer.. 102. 2017
Poor Sleep Quality Predicts Hypogonadal Symptoms and Sexual Dysfunction in Male Nonstandard Shift Workers.. 102. 2016
A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer.. 102. 2016
Vasectomy Reversal Surgical Patterns: An Analysis of the American Board of Urology Case Logs.. 107. 2016
Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.. 103. 2016
Outcomes and Prognostic Factors of Primary Urethral Cancer.. 100. 2016
A Plea for the Development of New Benign Prostatic Obstruction Follow-up Guidelines.. 99. 2016
The Evolving Management of Patients With Clinical Stage I Seminoma.. 98. 2016
Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series.. 98. 2016
Commentary: Does Asymptomatic Bacteriuria Reduce the Risk of Recurrence of Non-muscle-invasive Bladder Tumors?. 98. 2016
An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.. 96. 2016
A Prospective Randomized Trial of the Effects of Early Enteral Feeding After Radical Cystectomy.. 96. 2016
Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.. 95. 2016
International Medical Graduate Training in Urology: Are We Missing an Opportunity?. 95. 2016
Impact of Ureteroscopy Before Nephroureterectomy for Upper Tract Urothelial Carcinoma on Oncologic Outcomes.. 94. 2016
Pelvic Lymph Node Dissection in Patients Treated for Testis Cancer: The Memorial Sloan Kettering Cancer Center Experience.. 95. 2016
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract.. 94. 2016
Utilization of Preoperative Laboratory Testing for Low-risk, Ambulatory Urologic Procedures.. 94. 2016
Women in Urology Residency, 1978-2013: A Critical Look at Gender Representation in Our Specialty.. 92. 2016
Experienced Open vs Early Robotic-assisted Laparoscopic Radical Prostatectomy: A 10-year Prospective and Retrospective Comparison.. 91. 2016
Laser Vaporization of the Prostate With the 180-W XPS-Greenlight Laser in Patients With Ongoing Platelet Aggregation Inhibition and Oral Anticoagulation.. 91. 2016
Solifenacin and Tamsulosin Combination Therapy Decreases Urine Nerve Growth Factor/Creatinine Levels in Men.. 91. 2016
Age, Body Mass Index, and Frequency of Sexual Activity are Independent Predictors of Testosterone Deficiency in Men With Erectile Dysfunction.. 90. 2015
Increased Body Mass Index in Men With Varicocele Is Associated With Larger Spermatic Vein Diameters When Supine.. 89. 2015
Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis.. 88. 2015
Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: A Population-based Study.. 89. 2015
Long-term Impact of Androgen-deprivation Therapy on Cardiovascular Morbidity After Radiotherapy for Clinically Localized Prostate Cancer.. 87. 2015
The Correlation of Media Ranking's "Best" Hospitals and Surgical Outcomes Following Radical Cystectomy for Urothelial Cancer.. 86. 2015
New Chronic Kidney Disease and Overall Survival After Nephrectomy for Small Renal Cortical Tumors.. 86. 2015
Trends in Mesh Use for Pelvic Organ Prolapse Repair From the Medicare Database.. 86. 2015
Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications.. 86. 2015
Revision Techniques After Artificial Urinary Sphincter Failure in Men: Results From a Multicenter Study.. 86. 2015
Partial and Radical Nephrectomy for Unilateral Synchronous Multifocal Renal Cortical Tumors.. 85. 2015
Effect of Tadalafil Once Daily on Penile Length Loss and Morning Erections in Patients After Bilateral Nerve-sparing Radical Prostatectomy: Results From a Randomized Controlled Trial.. 85. 2015
Four flawed arguments against prostate-specific antigen screening (and 1 good one).. 85. 2015
Joseph J. Kaufman: renaissance man.. 85. 2015
A cost-effectiveness analysis of management of low-risk non-muscle-invasive bladder cancer using office-based fulguration.. 85. 2015
Assessment of the quality-of-life and functional outcomes in patients undergoing cystectomy and urinary diversion for the management of radiation-induced refractory benign disease.. 85. 2015
Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients.. 85. 2015
Decision analysis of dutasteride use for patients with negative prostate biopsy.. 85. 2015
Cost comparison of open and robotic partial nephrectomy using a short postoperative pathway.. 85. 2015
Evolution of laparoscopic donor nephrectomy technique and outcomes: a single-center experience with more than 1300 cases.. 85. 2015
Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form.. 85. 2015
Surgical competency for urethrovesical anastomosis during robot-assisted radical prostatectomy: development and validation of the robotic anastomosis competency evaluation.. 85. 2015
The fate of transitional urology patients referred to a tertiary transitional care center.. 84. 2014
Split-cuff nipple technique of ureteral reimplantation in children with thick-walled bladders due to posterior urethral valves.. 85. 2014
Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinoma.. 84. 2014
The role of ultrasonography in predicting vesicoureteral reflux.. 84. 2014
Comparison of perioperative outcomes of retroperitoneal and transperitoneal minimally invasive partial nephrectomy after adjusting for tumor complexity.. 84. 2014
Who really benefits from nephron-sparing surgery?. 84. 2014
Adult prostate sarcoma: the Memorial Sloan Kettering experience.. 84. 2014
Prostate size and adverse pathologic features in men undergoing radical prostatectomy.. 84. 2014
Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups.. 84. 2014
Effect of tadalafil once daily on prostate blood flow and perfusion in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, double-blind, multicenter, placebo-controlled trial.. 84. 2014
Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption.. 83. 2014
Prostate Cancer Prevention Trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer.. 83. 2014
Counseling the post-radical prostatectomy patients about functional recovery: high predictiveness of current status.. 84. 2014
The impact of radical prostatectomy operative time on outcomes and costs.. 83. 2014
Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.. 83. 2014
Clinicopathologic features of renomedullary interstitial cell tumor presenting as the main solid renal mass.. 83. 2014
Population-based comparative effectiveness of salvage radical prostatectomy vs cryotherapy.. 83. 2014
Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens.. 83. 2014
The role of magnetic resonance imaging in delineating clinically significant prostate cancer.. 83. 2014
Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis.. 83. 2014
Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years.. 82. 2013
Translabial ultrasonography for evaluation of synthetic mesh in the vagina.. 83. 2013
180 W vs 120 W lithium triborate photoselective vaporization of the prostate for benign prostatic hyperplasia: a global, multicenter comparative analysis of perioperative treatment parameters.. 82. 2013
Midurethral sling is the dominant procedure for female stress urinary incontinence: analysis of case logs from certifying American Urologists.. 82. 2013
Primary retroperitoneal lymph node dissection in low-stage testicular germ cell tumors: a detailed pathologic study with clinical outcome analysis with special emphasis on patients who did not receive adjuvant therapy.. 82. 2013
A retrospective review of office-based 532-nm GreenLight laser prostatectomy in men with symptomatic benign prostatic hyperplasia.. 82. 2013
Effect of visceral obesity on minimally invasive partial nephrectomy.. 82. 2013
Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation.. 82. 2013
Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.. 82. 2013
Management of anastomotic stricture after artificial urinary sphincter placement in patients who underwent salvage prostatectomy.. 82. 2013
Varicocelectomy is associated with increases in serum testosterone independent of clinical grade.. 81. 2013
Factors associated with reduction in use of neoadjuvant androgen suppression therapy before radical prostatectomy.. 81. 2013
Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.. 81. 2013
Management of bladder cancer after renal transplantation.. 81. 2013
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.. 81. 2013
International variation in artificial urinary sphincter use.. 80. 2012
Assessing renal function after partial nephrectomy using renal nuclear scintigraphy and estimated glomerular filtration rate.. 80. 2012
Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers.. 80. 2012
A modification to augmentation cystoplasty with catheterizable stoma for neurogenic patients: technique and long-term results.. 80. 2012
Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.. 80. 2012
Pubovesical fistula: a rare complication after treatment of prostate cancer.. 80. 2012
Higher RENAL Nephrometry Score is predictive of longer warm ischemia time and collecting system entry during laparoscopic and robotic-assisted partial nephrectomy.. 79. 2012
Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy.. 79. 2012
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy.. 79. 2012
Intraoperative mannitol use does not improve long-term renal function outcomes after minimally invasive partial nephrectomy.. 79. 2012
Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.. 79. 2012
Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer.. 79. 2012
Relative efficacy of perioperative gemcitabine and cisplatin versus methotrexate, vinblastine, adriamycin, and cisplatin in the management of locally advanced urothelial carcinoma of the bladder.. 79. 2011
We need a better marker for prostate cancer. How about renaming PSA?. 79. 2011
Body mass index is associated with higher lymph node counts during retroperitoneal lymph node dissection.. 79. 2011
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.. 78. 2011
New data, new paradigms for treating prostate cancer patients--VI: novel hormonal therapy approaches.. 78. 2011
The use of tissue expanders for resurfacing of the penis for hypospadias cripples.. 78. 2011
Comparison of laparoendoscopic single-site donor nephrectomy and conventional laparoscopic donor nephrectomy: donor and recipient outcomes.. 78. 2011
The effects of acute and chronic psychological stress on bladder function in a rodent model.. 78. 2011
Models to predict positive prostate biopsies using the Tyrol screening study.. 78. 2011
Ethnic differences in bladder cancer survival.. 78. 2011
Retroperitoneal histologic findings of patients with elevated serum alpha-fetoprotein and pure seminoma at orchiectomy.. 78. 2011
Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.. 78. 2011
Great meaningless questions in urology: which is better, open, laparoscopic, or robotic radical prostatectomy?. 77. 2011
Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer.. 77. 2011
Simple, age-based formula for predicting renal length in children.. 78. 2011
Is right-sided laparoendoscopic single-site donor nephrectomy feasible?. 77. 2011
Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an update.. 77. 2011
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.. 77. 2011
Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer.. 77. 2010
Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma.. 77. 2010
Contemporary lymph node counts during primary retroperitoneal lymph node dissection.. 77. 2010
Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model.. 77. 2010
Ethnic variation in pelvimetric measures and its impact on positive surgical margins at radical prostatectomy.. 76. 2010
Her-2/neu expression in testicular cancer--a retrospective analysis in 57 cases.. 76. 2010
Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancer.. 76. 2010
Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer.. 76. 2010
Development and validation of preoperative nomogram for disease recurrence within 5 years after laparoscopic radical prostatectomy for prostate cancer.. 77. 2010
Misconceptions and miscommunication among aging women with overactive bladder symptoms.. 77. 2010
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.. 76. 2010
The role of preoperative endo-rectal coil magnetic resonance imaging in predicting surgical difficulty for robotic prostatectomy.. 76. 2010
Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men.. 77. 2010
Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy.. 76. 2010
Does prior abdominal surgery influence outcomes or complications of robotic-assisted laparoscopic radical prostatectomy?. 76. 2010
Predictors of inguinal hernia after radical prostatectomy.. 77. 2010
Ureteroileal anastomosis with intraluminal visualization: technique and outcomes.. 76. 2010
ERG rearrangement metastasis patterns in locally advanced prostate cancer.. 75. 2010
Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s).. 76. 2010
The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.. 75. 2010
Efficacy and safety of tolterodine extended release and dutasteride in male overactive bladder patients with prostates >30 grams.. 75. 2010
Extended pelvic lymph node dissection in robotic-assisted radical prostatectomy: surgical technique and initial experience.. 75. 2010
Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.. 75. 2010
Efficacy of tamsulosin in the management of lower ureteral stones: a randomized double-blind placebo-controlled study of 100 patients.. 75. 2010
Economic costs of overactive bladder in the United States.. 75. 2009
A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.. 75. 2009
Critical evaluation of perioperative complications in laparoscopic partial nephrectomy.. 75. 2009
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.. 75. 2009
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.. 75. 2009
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.. 74. 2009
Why can't nomograms be more like Netflix?. 75. 2009
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.. 75. 2009
Thromboembolic complications of sling surgery for stress urinary incontinence among female Medicare beneficiaries.. 74. 2009
Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.. 75. 2009
Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.. 75. 2009
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?. 74. 2009
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.. 74. 2009
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.. 74. 2009
Prostate-specific antigen bounce after intensity-modulated radiotherapy for prostate cancer.. 76. 2009
The COMPARE Registry: design and baseline patterns of care for men with biochemical failure after definitive treatment of localized prostate cancer.. 75. 2009
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.. 74. 2009
Trends in surgical management of stress urinary incontinence among female Medicare beneficiaries.. 74. 2009
Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 2.. 73. 2009
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.. 73. 2009
Urodynamic testing in evaluation of postradical prostatectomy incontinence before artificial urinary sphincter implantation.. 73. 2009
Evaluation of bladder insufflants for transurethral cryoablation of the bladder.. 73. 2009
Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram.. 73. 2009
Association of sexual dysfunction with lower urinary tract symptoms of BPH and BPH medical therapies: results from the BPH Registry.. 73. 2009
Antitumor effects of an imidazoquinoline in renal cell carcinoma.. 73. 2009
Conventional treatments of localized prostate cancer.. 72. 2008
Evaluating localized prostate cancer and identifying candidates for focal therapy.. 72. 2008
Focal therapy for prostate cancer: analysis by an international panel.. 72. 2008
New treatments for localized prostate cancer.. 72. 2008
Prostate cancer: epidemiology and health-related quality of life.. 72. 2008
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.. 73. 2008
Sex hormone-binding globulin: a novel marker for nodal metastases prediction in prostate cancer patients undergoing extended pelvic lymph node dissection.. 73. 2008
Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer.. 73. 2008
Direct comparison of surgical and functional outcomes of robotic-assisted versus pure laparoscopic radical prostatectomy: single-surgeon experience.. 73. 2008
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.. 73. 2008
Point: effect of radiation-associated second malignancies on prostate cancer survival.. 72. 2008
Spiral sling salvage anti-incontinence surgery for women with refractory stress urinary incontinence: surgical outcome and satisfaction determined by patient-driven questionnaires.. 72. 2008
Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.. 72. 2008
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.. 72. 2008
A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer.. 72. 2008
Variations in surgeon volume and use of pelvic lymph node dissection with open and minimally invasive radical prostatectomy.. 72. 2008
Optical coherence tomography as an adjunct to white light cystoscopy for intravesical real-time imaging and staging of bladder cancer.. 72. 2008
Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy.. 72. 2008
Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer.. 72. 2008
Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery.. 72. 2008
Determinants of treatment regret in low-income, uninsured men with prostate cancer.. 72. 2008
Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.. 71. 2008
Patient perceived outcomes of treatments used for interstitial cystitis.. 71. 2008
Prognostic significance of location of positive margins in radical prostatectomy specimens.. 70. 2007
Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.. 70. 2007
Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.. 70. 2007
Simultaneous vasectomy and varicocelectomy: indications and technique.. 70. 2007
Age and outcome of superficial bladder cancer treated with bacille Calmette-Guérin therapy.. 70. 2007
Distinct patterns of endothelin axis expression in primary prostate cancer.. 70. 2007
Use of hydrophilic-coated urethral catheters in management of acute urinary retention.. 70. 2007
Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma.. 69. 2007
Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy.. 69. 2007
Tumor location does not affect long-term renal function after partial nephrectomy.. 69. 2007
Anatomic restoration technique of continence mechanism and preservation of puboprostatic collar: a novel modification to achieve early urinary continence in men undergoing robotic prostatectomy.. 69. 2007
Innovative single-armed suture technique for microsurgical vasoepididymostomy.. 69. 2007
Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm.. 69. 2007
Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.. 69. 2007
Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.. 69. 2007
Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.. 69. 2007
Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.. 69. 2007
Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder.. 69. 2007
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.. 68. 2006
Microsurgical inguinal varicocelectomy with and without testicular delivery.. 68. 2006
Perioperative clinical thromboembolic events after radical or partial nephrectomy.. 68. 2006
Feasibility of laparoscopic approach in management of xanthogranulomatous pyelonephritis.. 68. 2006
Persistent prostate-specific antigen expression after neoadjuvant androgen depletion: an early predictor of relapse or incomplete androgen suppression.. 68. 2006
Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy.. 68. 2006
Urodynamic predictors of outcomes with photoselective laser vaporization prostatectomy in patients with benign prostatic hyperplasia and preoperative retention.. 68. 2006
Percutaneous renal cryoablation.. 68. 2006
Complications after radical cystectomy: analysis of population-based data.. 68. 2006
Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablation.. 67. 2006
The use of urine-based biomarkers in bladder cancer.. 67. 2006
True prevalence of urinary incontinence among female nursing home residents.. 67. 2006
Perineocele: symptom complex, description of anatomic defect, and surgical technique for repair.. 67. 2006
Extracorporeal shock wave lithotripsy monotherapy for treatment of patients with urethral and bladder stones presenting with acute urinary retention.. 66. 2005
Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?. 66. 2005
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.. 66. 2005
Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome.. 66. 2005
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta").. 66. 2005
Transvaginal paravaginal repair of high-grade cystocele central and lateral defects with concomitant suburethral sling: report of early results, outcomes, and patient satisfaction with a new technique.. 66. 2005
Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.. 66. 2005
Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.. 66. 2005
Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi.. 66. 2005
Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.. 66. 2005
Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer.. 66. 2005
In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats.. 66. 2005
Anterior vaginal wall surgery in elderly patients: outcomes and assessment.. 65. 2005
Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population.. 65. 2005
Inheritance of varicoceles.. 65. 2005
Structural and functional changes to the testis after conventional versus microdissection testicular sperm extraction.. 65. 2005
Androgen deprivation for minimal metastatic disease: threshold for achieving undetectable prostate-specific antigen.. 65. 2005
Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.. 65. 2005
Comparison of nephron-sparing surgery in central versus peripheral renal tumors.. 65. 2005
Impact of vaginal surgery for stress urinary incontinence on female sexual function: is the use of polypropylene mesh detrimental?. 65. 2005
Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.. 65. 2005
High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.. 64. 2004
Botulinum toxin a has antinociceptive effects in treating interstitial cystitis.. 64. 2004
Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure-flow study parameters in clinically obstructed women with those of normal controls.. 64. 2004
Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.. 64. 2004
Intraoperative characterization of arterial vasculature in spermatic cord.. 64. 2004
Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.. 64. 2004
Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.. 64. 2004
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy.. 63. 2004
Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.. 63. 2004
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.. 63. 2004
Testosterone treatment of human foreskin in a novel transplant model.. 63. 2004
Evaluation of water jet morcellation as an alternative to hand morcellation of renal tissue ablation during laparoscopic nephrectomy: an in vitro study.. 63. 2004
Role of voided urine cytology in diagnosing primary urethral carcinoma.. 63. 2004
Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease.. 62 Suppl 1. 2003
Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology.. 62. 2003
Dietary manipulation, ethnicity, and serum PSA levels.. 62. 2003
Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome.. 62. 2003
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.. 62. 2003
Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms.. 62. 2003
Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder.. 61. 2003
Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder.. 61. 2003
Long-term follow-up of bilateral sporadic renal tumors.. 61. 2003
Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results.. 61. 2003
Biochemical profile of stone-forming patients with diabetes mellitus.. 61. 2003
Correlation of preoperative levels of IGF-I and IGFBP-3 with pathologic parameters and clinical outcome in patients with bladder cancer.. 61. 2003
Cross-cultural validation of the UCLA prostate cancer index.. 61. 2003
Estimating survival benefit in castrate metastatic prostate cancer: decision making in proceeding to a definitive phase III trial.. 61. 2003
Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy.. 61. 2003
Hand-assisted laparoscopy for large renal specimens: a multi-institutional study.. 61. 2003
High expression of the Met receptor in prostate cancer metastasis to bone.. 60. 2002
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia.. 60. 2002
Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome.. 60. 2002
Impact of a second transurethral resection on the staging of T1 bladder cancer.. 60. 2002
PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: preliminary study.. 60. 2002
Blood loss during radical retropubic prostatectomy: relationship to morphologic features on preoperative endorectal magnetic resonance imaging.. 59. 2002
Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer.. 59. 2002
Natural history of chronic renal insufficiency after partial and radical nephrectomy.. 59. 2002
Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor.. 59. 2002
Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience.. 59. 2002
Bilateral nerve grafting during radical retropubic prostatectomy: extended follow-up.. 58. 2001
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis.. 58. 2001
Polypropylene sling for the treatment of stress urinary incontinence.. 58. 2001
Effective long-term androgen suppression in men with prostate cancer using a hydrogel implant with the GnRH agonist histrelin.. 58. 2001
Hand-assisted demucosalized gastrocystoplasty comparing different tissue closure methods.. 58. 2001
Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer.. 58. 2001
Radiographic versus pathologic size of renal tumors: implications for partial nephrectomy.. 58. 2001
Nitric oxide synthase activity in human seminal plasma.. 58. 2001
Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma.. 57. 2001
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia.. 57. 2001
Does nocturnal deactivation of the artificial urinary sphincter lessen the risk of urethral atrophy?. 57. 2001
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology.. 57. 2001
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up.. 57. 2001
Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.. 57. 2001
Primary genitourinary melanoma.. 57. 2001
Histologic effects of testicular sperm extraction on the testicle in men with nonobstructive azoospermia.. 57. 2001
Interposition sural nerve grafting during radical retropubic prostatectomy.. 57. 2001
Urodynamic pattern changes in multiple sclerosis.. 57. 2001
E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.. 57. 2001
Is fascia lata allograft material trustworthy for pubovaginal sling repair?. 56. 2000
Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder.. 56. 2000
Correlation of preoperative plasma IGF-I levels with pathologic parameters and progression in patients undergoing radical prostatectomy.. 56. 2000
Second primary malignancies associated with renal cell carcinoma: influence of histologic type.. 56. 2000
Update on impact of moderate dose of adjuvant radiation on urinary continence and sexual potency in prostate cancer patients treated with nerve-sparing prostatectomy.. 56. 2000
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging.. 56. 2000
Survey of neuromuscular injuries to the patient and surgeon during urologic laparoscopic surgery.. 55. 2000
Clinical states in prostate cancer: toward a dynamic model of disease progression.. 55. 2000
Laser-assisted demucosalized gastrocystoplasty with autoaugmentation in a canine model.. 55. 2000
Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial.. 55. 2000
Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection.. 55. 2000
Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial.. 54. 1999
Serum testosterone levels in African-American and white men undergoing prostate biopsy.. 54. 1999
Race is not an independent predictor of positive surgical margins after radical prostatectomy.. 54. 1999
Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.. 54. 1999
Expression of vascular endothelial growth factor receptors in human prostate cancer.. 54. 1999
Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma.. 54. 1999
Adjuvant radiotherapy in patients with pathologic Stage C (pT3N0) adenocarcinoma of the prostate.. 53. 1999
Comparison of absorbable and nonabsorbable sutures for microsurgical vasovasostomy in rats.. 53. 1999
Impact of chronic dialysis on serum PSA, free PSA, and free/total PSA ratio: is prostate cancer detection compromised in patients receiving long-term dialysis?. 53. 1999
Male urethral carcinoma: analysis of treatment outcome.. 53. 1999
Endoscopic surgery and telemedicine in microgravity: developing contingency procedures for exploratory class spaceflight.. 53. 1999
Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate.. 53. 1999
Near-infrared confocal laser scanning microscopy of bladder tissue in vivo.. 53. 1999
Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer.. 53. 1999
Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction.. 53. 1999
Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer.. 53. 1999
Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial.. 53. 1999
Effect of methylene blue, indigo carmine, and Renografin on human sperm motility.. 53. 1999
Recall and attitudes in patients with prostate cancer.. 53. 1999
Restoration of spermatogenesis after scrotal replacement of experimentally cryptorchid rat testis: assessment of germ cell apoptosis and eNOS expression.. 53. 1999
Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.. 52. 1998
Increased incidence of depressive symptoms in men with erectile dysfunction.. 52. 1998
Testicular sperm extraction for nonobstructive azoospermia: results of a multibiopsy approach with optimized tissue dispersion.. 52. 1998
Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.. 52. 1998
Intravesical bacille Calmette-Guérin induces the antiangiogenic chemokine interferon-inducible protein 10.. 52. 1998
Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors.. 52. 1998
Impact of a clinical pathway for radical retropubic prostatectomy.. 52. 1998
Intermittent alpha-blocker therapy in the treatment of men with lower urinary tract symptoms.. 52. 1998
Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost.. 51. 1998
Human sperm NADH and NADPH diaphorase cytochemistry: correlation with sperm motility.. 51. 1998
Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells.. 51. 1998
Assessment of the feasibility and impact of shared decision making in prostate cancer.. 51. 1998
Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group.. 50. 1997
Correlation of urodynamic results and urethral coaptation with success after transurethral collagen injection.. 50. 1997
Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination.. 50. 1997
Improved detection of recurrent bladder cancer using the Bard BTA stat Test.. 50. 1997
Reduction in testicular temperature after varicocelectomy in infertile men.. 50. 1997
Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer.. 50. 1997
Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma.. 50. 1997
Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder.. 49. 1997
Assessment of endpoints for clinical trials for localized prostate cancer.. 49. 1997
Assessment of hormone refractory prostate cancer.. 49. 1997
Planning controlled clinical trials. Prostatic cancer.. 49. 1997
Clinical significance of repeat sextant biopsies in prostate cancer patients.. 49. 1997
Does current chemotherapy improve survival of patients with invasive bladder cancer?. 49. 1997
Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers.. 49. 1997
Ileovesicostomy as an alternative form of bladder management in tetraplegic patients.. 49. 1997
Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy.. 49. 1997
Testicular sperm extraction with intracytoplasmic sperm injection for nonobstructive azoospermia.. 49. 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.. 49. 1997
Transurethral electrovaporization of the prostate: one-year experience.. 48. 1996
Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.. 48. 1996
Transurethral electrovaporization of bladder cancer.. 48. 1996
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies.. 48. 1996
Comparison of fascial and vaginal wall slings in the management of intrinsic sphincter deficiency.. 47. 1996
Etiology of voiding dysfunction in men less than 50 years of age.. 47. 1996
Acid phosphatase: defining a role in androgen-independent prostate cancer.. 47. 1996
Routine CT scan in cystectomy patients: does it change management?. 47. 1996
Surgical resection of brain metastases from renal cell carcinoma in 50 patients.. 47. 1996
A simplified method of epididymal sperm aspiration.. 47. 1996
Intravesicular carboprost for the treatment of hemorrhagic cystitis after marrow transplantation.. 46. 1995
Is prostate-specific antigen density more useful than prostate-specific antigen levels in the diagnosis of prostate cancer?. 46. 1995
Micropuncture retrieval of epididymal sperm with in vitro fertilization: importance of in vitro micromanipulation techniques.. 46. 1995
Laparoscopic laser-assisted bladder autoaugmentation.. 46. 1995
Use of a catheter limiter during intermittent catheterization.. 45. 1995
Distinguishing prognostic and treatment-predictive information for localized prostate cancer.. 45. 1995
Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia.. 45. 1995
Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.. 45. 1995
Laser tissue welding in genitourinary reconstructive surgery: assessment of optimal suture materials.. 45. 1995
Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin.. 44. 1994
Telerobotic assisted laparoscopic surgery: initial laboratory and clinical experience.. 44. 1994
Xanthogranulomatous pyelonephritis: clinical findings and surgical considerations.. 43. 1994
Clinical follow-up in 24 nonfamilial renal tumors cytogenetically characterized in tissue culture.. 43. 1994
Heterogeneity of prostate cancer in radical prostatectomy specimens.. 43. 1994
Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy.. 43. 1994
Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination.. 42. 1993
Clinical experience with Mentor Alpha I inflatable penile prosthesis. Report on 333 cases.. 42. 1993
CO2 laser welding versus conventional microsuture repair in patch-graft urethroplasty.. 41. 1993
Surgical management of urethral strictures based on etiology. Where do urethral stents fit in?. 40. 1992
Use of silicone medical grade tubing for microsurgical vasovasostomy training.. 39. 1992
Use of infra-pubic incision for insertion of Mentor Mark II inflatable penile prosthesis.. 39. 1992
Detection of residual prostate cancer after radiotherapy by sonographically guided needle biopsy.. 39. 1992
External spermatic sheath injection for vasal nerve block.. 39. 1992
Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.. 38. 1991
Initial results with slightly modified Kock pouch.. 37. 1991
Management of penile gunshot wounds.. 36. 1990
Sonographic measurements of transition zone of prostate in men with and without benign prostatic hyperplasia.. 36. 1990
Surgical treatment of brain metastases from renal cell carcinoma.. 36. 1990
Transrectal sonography for serial evaluation of prostatic malignancy.. 36. 1990
Ureteral stent for nonrefluxing, continent urinary diversions. Reduces complications and hospitalization for patients.. 35. 1990
Conservative treatment of superficial transitional cell carcinoma of prostatic urethra with intravesical BCG.. 34. 1989
Method of circumferential pressure dressing of scrotum following bilateral orchiectomy.. 33. 1989
Thomas Hillier and percutaneous nephrostomy.. 33. 1989
Assessment of male infertility: correlation between results of semen analysis and phosphorus-31 magnetic resonance spectroscopy.. 33. 1989
Experience with potency preservation during radical prostatectomy. Significance of learning curve.. 32. 1988
Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial.. 32. 1988
The Kelly scrotal bridge.. 31. 1988
Cost-effectiveness of extracorporeal shock-wave lithotripsy.. 31. 1988
Correlation between intracavernous papaverine injection and Doppler analysis in impotent men.. 30. 1987
Octoson imaging in pediatric urology.. 30. 1987
Sonography in evaluation of carcinoma of bladder.. 29. 1987
Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.. 28. 1986
Use of occlusion balloon catheter in percutaneous renal stone extraction.. 27. 1986
Consideration for treatment of upper urinary tract tumors with topical therapy.. 26. 1985
Gleason grading of prostate cancer: a predictor of survival.. 25. 1985
Infarction-nephrectomy for metastatic renal carcinoma. Southwest oncology group study.. 25. 1985
Experience with intravesical bacillus Calmette-Guèrin therapy of superficial bladder tumors.. 25. 1985
Interstitial radiation: short-term palliation or curative therapy?. 25. 1985
Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy.. 25. 1985
Prostatic biopsy after irradiation therapy for prostatic cancer.. 25. 1985
Renal carbuncle: comparison between surgical open drainage and closed percutaneous drainage.. 25. 1985
Magnetic resonance imaging and its application in urology.. 23. 1984
Penile corporoplasty with polytetrafluoroethylene (PTFE) grafts.. 22. 1983
Impact of symptomatic interval on prognosis of patients with stage III testicular cancer.. 21. 1983
Lymphocele after pelvic lymphadenectomy for urologic cancer.. 17. 1981
Bivalve endoscopic sheath for direct vision insertion of urethral catheter.. 16. 1980
Complications of pelvic lymphadenectomy and retropubic prostatic 125I implantation.. 14. 1979
Recent advances in immunobiology of genitourinary cancer.. 9. 1977
Immunoglobulin A in split ejaculates of patients with prostatitis.. 9. 1977
Clinical use of immunoelectrophoresis of split ejaculates. I. Variation of patterns due to antisera.. 9. 1977
Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment.. 6. 1975
Sigmoid conduit urinary diversion.. 6. 1975
Metastatic carcinoma of prostate masquerading as abdominal aortic aneurysm.. 5. 1975
Letter: "Immunostaging" patients with malignant disease.. 05. 1975
Renal function after ligation of right renal vein.. 5. 1975
Scrotal aspiration: aid in early differentiation between torsion of spermatic cord and acute epididymo-orchitis.. 4. 1974
Bedside sphincterometry.. 4. 1974
Acute urinary retention in a child due to procolpos and pyometrium.. 3. 1974
Flucytosine in urinary candida infections.. 3. 1974
Left spermatic vein cortisol in subfertile men with varicocele.. 3. 1974
Lipogranulomatosis of external genitalia.. 3. 1974
Erythromycin plus sodium bicarbonate in chronic bacterial prostatitis.. 3. 1974
Familial vesicoureteral reflux.. 2. 1973
Hydronephrosis and hydroureter major problem in patients with spinal cord injury.. 2. 1973
Serum finding associated with carcinoma of kidney.. 2. 1973
Primary or pseudohyperparathyroidism?. 2. 1973
Penile tuberculosis.. 1. 1973
Pursuing Novel Ideas-Confessions of Lost Opportunities!. 107. 2017
Introduction: International consultation on urologic diseases: testicular cancer: Societe Internationale d'Urologie/International Consultation on Urologic Diseases Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009.. 78. 2011
Author Reply. 2022
EDITORIAL COMMENT. 2021
AUTHOR REPLY. 2020
AUTHOR REPLY. 2020
AUTHOR REPLY. 2020
AUTHOR REPLY. 2020
AUTHOR REPLY. 2020
EDITORIAL COMMENT. 2019
Editorial Comment. 2019
EDITORIAL COMMENT. 2019
EDITORIAL COMMENT. 2019
Author Reply. 2017
Author Reply. 2017
Editorial Comment. 2016
Editorial Comment. 2016
Editorial Comment. 2016
Implementation of Dynamically Updated Prediction Models at the Point of Care at a Major Cancer Center: Making Nomograms More Like Netflix. 2016
Editorial Comment. 2016
Author Reply. 2016
Reply: To PMID 26142590. 2015
Editorial comment. 2015
Reply: To PMID 25623680. 2015
Reply: To PMID 25623694. 2015
Editorial comment. 2014
Editorial comment. 2014
Editorial comment. 2014
Reply: To PMID 24094653. 2013
Reply: To PMID 23561709. 2013
Editorial comment. 2013
Editorial comment. 2013
Editorial comment. 2012
Editorial comment. 2009
Editorial comment. A new diagnosis of a small kidney tumor. 2009
Editorial comment. Patients with low-grade papillary bladder tumors could be monitored safely, deferring therapy unless the recurrent tumors increased in size or number. 2009
Editorial comment. 2009
Peter Lester Scardino--a genitourinary surgeon in third generation of the specialty: part 1. 2009
Editorial comment. 2001
Re: Selective Serotonin Reuptake Inhibitor (SSRI) Use Is Not Associated With Impaired Semen Parameters. 2023
Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2. 2021
AUTHOR REPLY. 2020
AUTHOR REPLY. 2020
Pelvic Hematoma following Urolift Procedure for BPH. 2019
A Thoughtful Pause for Sparing Oophorectomy. 2019
Efficacy of Cranberry in Preventing Recurrent Urinary Tract Infections: Have We Learned Anything New?: Commentary on: Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes: A Randomized Clinical Trial. 2016
Author Reply. 2016
Author Reply. 2016
Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. 2016
Author Reply. 2016
Author Reply. 2016
Reply to Letter to the Editor: Effect of Tadalafil Once Daily (OaD) on Penile Length Loss and Morning Erections in Patients Post Bilateral Nerve-sparing Radical Prostatectomy (nsRP): Results From a Randomized Controlled Trial (Urology 2015;85:1090-1096). 2015
Reply: To PMID 25586475. 2015
Reply: To PMID 25443935. 2014
Reply by the authors. 2014
Reply by the authors. 2013
Reply by the authors. 2013
Best practice policy statement on urologic surgery antimicrobial prophylaxis. 2009
Correlation of radiation dose and impotence risk after three-dimensional conformal radiotherapy for prostate cancer. 2001
Prostatitis: myths and realities. 1999
Assisted reproduction cost-effectiveness analysis. 1997
Non-Hodgkin's lymphoma can mimic renal adenocarcinoma with inferior vena caval involvement. 1994
Semen quality and chronic abacterial prostatitis. 1992
Use of miconazole as bladder irrigant. 1984
Microsurgical reimplantation of amputated penis. 1978
Partial Gland Ablation for Prostate Cancer: Report of a Food and Drug Administration, American Urological Association, and Society of Urologic Oncology Public Workshop. 2015
Drug and device development for localized prostate cancer: report of a Food and Drug Administration/American Urological Association public workshop. 2014
Challenges and recommendations for early identification of metastatic disease in prostate cancer. 2014
Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshop. 2013
North American consensus document on infection of penile prostheses. 2013
Gross hematuria and upper pole renal filling defect. 1991
Preventable Cancer Deaths Associated with Bladder Preservation for Muscle Invasive Bladder Cancer.. 130. 2019
Editorial Comment.. 85. 2015
Editorial comment.. 84. 2014
Editorial comment.. 84. 2014
Editorial comment.. 84. 2014
Reply: To PMID 24824406.. 84. 2014
Reply: To PMID 24768012.. 83. 2014
Editorial comment.. 82. 2013
Editorial comment.. 81. 2013
Editorial comment.. 80. 2012
Editorial comment.. 79. 2012
Editorial comment.. 79. 2012
Editorial comment.. 79. 2012
Editorial comment.. 78. 2011
Editorial comment.. 78. 2011
Editorial comment.. 78. 2011
Editorial comment.. 78. 2011
Editorial comment.. 78. 2011
Editorial comment.. 77. 2011
Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.. 77. 2011
Editorial comment.. 77. 2011
Editorial comment. Tumor grade at margins of resection in radical prostatectomy specimens is an independent predictor of prognosis.. 76. 2010
Editorial comment.. 76. 2010
Editorial comment.. 75. 2010
Editorial comment.. 75. 2010
Editorial comment.. 75. 2010
Editorial comment.. 75. 2010
Editorial comment.. 75. 2010
Editorial comment.. 75. 2010
Editorial comment.. 74. 2009
Editorial comment.. 74. 2009
Editorial comment.. 74. 2009
Editorial comment.. 74. 2009
Editorial comment. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications.. 74. 2009
Editorial comment. Variations in International Prostate Symptom scores, uroflowmetric parameters, and prostate volume after (125)I permanent brachytherapy for localized prostate cancer.. 74. 2009
Renal cryoablation: study with care--proceed with caution.. 65. 2005
Fresh testicular sperm from men with nonobstructive azoospermia works best for ICSI.. 64. 2004
Rationale for and results of nerve grafting during radical prostatectomy.. 57. 2001
Percent free prostate-specific antigen for first-time prostate biopsy.. 57. 2001
A Comparison of Microwave Ablation and Cryoablation for the Treatment of Renal Cell Carcinoma: A Systematic Literature Review and Meta-Analysis. 2023
Future of Male Infertility Evaluation and Treatment: Brief Review of Emerging Technology. 2022
Optimizing Nonsurgical Treatments of Overactive Bladder in the United States. 2020
Use of Botulinum Toxin A (BoNT-A) in Detrusor External Sphincter Dyssynergia (DESD): A Systematic Review and Meta-analysis. 2020
Healthcare Costs of Post-Prostate Biopsy Sepsis. 2019
Primary Urethral Melanoma: A Case Report and Literature Review. 2018
Metanephric Adenoma in the Pediatric Population: Diagnostic Challenges and Follow-up. 2018
What Is the Role of α-Blockers for Medical Expulsive Therapy? Results From a Meta-analysis of 60 Randomized Trials and Over 9500 Patients. 2018
Histologic Inflammatory Response to Transvaginal Polypropylene Mesh: A Systematic Review. 2017
The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II). 2017
Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review? 2016
Targeted Prostate Biopsy: Lessons Learned Midst the Evolution of a Disruptive Technology. 2015
Outcomes of microsurgical vasovasostomy for vasectomy reversal: a meta-analysis and systematic review. 2015
Clinical value of transurethral second resection of bladder tumor: systematic review. 2014
A commentary on PSA velocity and doubling time for clinical decisions in prostate cancer. 2014
A review of contemporary data on surgically resected renal masses--benign or malignant? 2013
Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). 2010
Complications associated with patient positioning in urologic surgery. 2010
The genetic and phenotypic basis of infertility in men with pediatric urologic disorders. 2010
Subcutaneous cod liver oil injection for penile augmentation: review of literature and report of eight cases. 2010
How close are we to knowing whether orthotopic bladder replacement surgery is the new gold standard?--evidence from a systematic review update. 2009
Granular cell tumor of the glans penis in a 9-year-old boy. 2008
Renal medullary carcinoma: the Bronx experience. 2007
Standards for surgical complication reporting in urologic oncology: time for a change. 2007
Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. 2007
No-scalpel, no-needle vasectomy. 2006
A meta-analysis of the performance characteristics of the free prostate-specific antigen test. 2006
Chemoprevention of bladder cancer. 2006
DNA-based molecular cytology for bladder cancer surveillance. 2006
The diagnosis and staging of bladder cancer: from RBCs to TURs. 2006
The management of superficial transitional cell carcinoma of the bladder. 2006
The pathology of bladder cancer. 2006
Therapy of invasive bladder cancer. 2006
Urothelial cancer biomarkers for detection and surveillance. 2006
Ureteroscopic management of renal calculi in anomalous kidneys. 2005
Novel approaches to treat asymptomatic, hormone-naive patients with rising prostate-specific antigen after primary treatment for prostate cancer. 2003
Clinical outcome after retroperitoneal lymphadenectomy of patients with pure testicular teratoma. 2003
Fatal respiratory failure associated with treatment of prostate cancer using docetaxel and estramustine. 2002
Squamous cell carcinoma in a female urethral diverticulum. 2002
Large granular cell tumor of the penis in a 53-year-old man with coexisting prostate cancer. 2002
Significance of the polyglutamine tract polymorphism in the androgen receptor. 2001
Gene therapy for prostate cancer. 2001
Recent advances in the management of the neurogenic bladder. 2000
Prostate-specific membrane antigen: present and future applications. 2000
Renal artery thrombosis in the newborn infant. 1997
Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy. 1997
Plexiform neurofibroma involving the genitourinary tract in children: case reports and review of the literature. 1997
Is assisted reproduction the optimal treatment for varicocele-associated male infertility? A cost-effectiveness analysis. 1997
Computer modeling in urology. 1996
Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer. 1996
Bilateral renal oncocytomatosis in a patient with renal failure. 1995
Hemospermia: diagnosis and management. 1995
Hormone-refractory (D3) prostate cancer: refining the concept. 1995
Urologic causes of gynecomastia: approach to diagnosis and management. 1995
Nonseminomatous germ cell tumors of the testis: current concepts and controversies. 1994
Laser tissue welding in urologic surgery. 1994
Transrectal ultrasound in management of prostate cancer. 1989
Primary signet-ring cell carcinoma of urinary bladder. 1988
Ureteral replacements. 1975

VIVO Weill Cornell Medical College

Urology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)